MedTrace Logo

Propofol for Prophylaxis of Morphine Induced Pruritis in Caesarean Section

NCT06188546 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2024-01-03

No results posted yet for this study

Summary

the goal of this randomized clinical trial is to find the optimum sub hypnotic dose of iv propofol that prevents the incidence of itching induced from intrathecal morphine used in spinal anesthesia in caesarean section operation. the main questions it aim to answer are the number of patients complained of pruritus in the first 24 hours post operative period and the severity of the pruritus. participants will be divided into 4 groups. 1st group receives 0 mg of propofol , 2nd receives 10 mg , 3rd receives 20 mg and the 4th receives 30 mg.

Conditions

  • Pruritus Caused by Drug

Interventions

DRUG

Propofol

trying different dosages of propofol 10mg/ml IV to determine the prophylactic dose for morphine induced pruritis

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Zein Zarea, MD · Assiut University

  • Diab Fuad Hetta, MD · South Egypt's cancer institute

  • Rania Mohamed Abdelemam, MD · South Egypt's cancer institute

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2025-01-01
Completion
2025-03-01
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06188546 on ClinicalTrials.gov